A startup from Boston has developed an AI platform, ActivEdge to collect data during operations and surgeons in the visualization of internal organs in real time. The ultimate goal of Surgical Activ – creating a robot that will initially support operations with the participation of the person, and then completely replace it.
Robotic surgery began to evolve in the 1980-ies, and the first successful prototype was the robot Da Vinci. Now the United States has launched more than 6,000 such robots, and the number of operations exceeded 2 million, says TechCrunch.
It should be noted that the robot does not replace Vimci Da man, and works as a backup for the surgeon-operator, which controls the manipulators. Engineers Activ Surgical support this type of interaction, although I think that this is a transitional phase before full automation.
“The future of surgery is a collaboration. The judgment and wisdom of man can be complemented by the precision of robotics,” said CEO Todd ussen.
A feature of the system ActivEdge
ActivEdge is a software system for artificial intelligence and machine learning that collects data using sensors that are attached to surgical equipment. First Activ Surgical will work to integrate its technology in a 2.2 million laparoscopic operations per year. ActivEdge will be used for cholecystectomy, colectomy, hysterectomy, and gastrectomy.
The company will use the most popular process for fluorescent imaging, which was not previously available in real time. Hardware Activ Surgical technology may already be connected to laparoscopic and arthroscopic systems.
In the future ussen plans to bring the device to the self-understanding of the surgical processes and offer software for robotic surgeons of the new generation.
“We want to make surgery more reliable, taking into account all the advantages of Autonomous robotics and bringing it to real practice, to prove the viability of our concept,” says Todd ussen.
What will change a new robotic system
Hardware and software Activ is aimed at reducing medical errors annually lead to the deaths of 400,000 people in the United States. Human error in the health care system is the third leading cause of death after heart attacks and cancer, and 26% of these errors occurs during the operation. In addition, hospitals and other medical institutions suffer losses up to $ 36 billion annually due to the human factor.
Activ Surgical has already attracted investments in the amount of $ 15 million from ARTIS Ventures of the conglomerate. Participation in the round of financing adopted by leading venture capital funds, including LRVHealth, DNS Capital, GreatPoint Ventures, Tao Capital Partners and Rising Tide VC.
Share the news